University of Alabama Investigator Earns FDA Grant for First-in-Human Viral Immunotherapy for Pediatric Brain Tumors

University of Alabama Investigator Earns FDA Grant for First-in-Human Viral Immunotherapy for Pediatric Brain Tumors

Dr. Gregory Friedman of the University of Alabama at Birmingham (UAB) received a three-year, $750,000 R01 grant from the U.S. Food and Drug Administration (FDA) for a Phase I immunotherapy clinical trial of engineered cold-sore (or herpes) virus G207 for the treatment...

Pin It on Pinterest